ライフサイエンスコーパス: mastocytoma

1 the adjunct solitary from the term solitary mastocytoma.

2 ammary adenocarcinoma, glioma, leukemia, and mastocytoma.

3 ntaneous transformation ex vivo; and P815, a mastocytoma.

4 n a malignant fashion, unlike human solitary mastocytomas.

5 s in both primary mast cells and transformed mastocytomas, although with a smaller IC(50) value in th

6 interfere with the GVT effect, because P815 mastocytoma and most importantly primary Bcr-Abl-transfo

7 ate chymase and tryptase mRNA levels between mastocytoma and non-mast cells.

8 mice transplanted with the immunogenic P815 mastocytoma and showed that it significantly enhanced th

9 ponse against two B7- tumors, the mouse P815 mastocytoma and the E7C3 melanoma, requires host-derived

10 Finally, IL-3-independent mastocytomas and mast cell lines were resistant to apopt

11 analyses of non-T cells, including B cells, mastocytoma, and fibroblasts, by Northern blot analysis

12 cyte cell lines, including T and B lymphoma, mastocytoma, and macrophage lines.

13 dicted from a cDNA clone we sequenced from a mastocytoma cDNA library.

14 NECA increases canine mastocytoma cell cAMP, Ca2+, and inositol trisphosphate

15 r experiments using highly purified enzymes, mastocytoma cell chymase activated 92-kD progelatinase i

16 gical inhibition of CD39 in a cultured human mastocytoma cell line (HMC-1) and murine bone marrow-der

17 Compared to the C2 mastocytoma cell line harboring a Kit exon 11 mutation,

18 F) was expressed on the surface of the mouse mastocytoma cell line P815 to target tumor cell-associat

19 We found the dog C2 mastocytoma cell line to be the richest source yet descr

20 We established a novel canine mastocytoma cell line, NI-1, from a patient suffering fr

21 ty, we immunized PLRP2-deficient mice with a mastocytoma cell line, P815, and determined the ability

22 d to clone the full-length cDNA from a mouse mastocytoma cell line.

23 d from fibrosarcoma, lymphoma, melanoma, and mastocytoma cell lines.

24 hat a metallogelatinase is secreted from dog mastocytoma cells and directly activated by exocytosed m

25 iments, animals also received host-type P815 mastocytoma cells at the time of BMT.

26 Animals also received host-type P815 mastocytoma cells at the time of BMT.

27 Like BR cells, the C2 line of dog mastocytoma cells constitutively secrete progelatinase B

28 Although canine BR mastocytoma cells contain A1AR, A2BAR, and A3AR, degranu

29 Dog mastocytoma cells incubated with 12-O-tetradecanoylphorb

30 In dog BR mastocytoma cells incubated with phorbol ester, high ste

31 nase activity secreted by the BR line of dog mastocytoma cells reveals a phorbol-inducible, approxima

32 These data demonstrate that dog mastocytoma cells secrete a metalloproteinase related to

33 Thus, dog mastocytoma cells secrete DPPI that is active at the pH

34 e presence of B7/BBl-transfected P815 murine mastocytoma cells underscoring an SLE-associated defect

35 Degranulation of mastocytoma cells using ionophore A23187 greatly acceler

36 P815 mastocytoma cells were used as cell-associated antigens

37 t form expressed in pineal gland and in P815 mastocytoma cells with a molecular weight of 51 kDa.

38 Coincubation of chymase-rich BR mastocytoma cells with Ala-Ala-Pro-Phe-chloromethylketon

39 coded by an abundant 4.6-kilobase mRNA, like mastocytoma cells, has 70% amino acid sequence identity

40 The current work demonstrates that dog BR mastocytoma cells, HMC-1 cells, and murine bone marrow-d

41 xtracellular roles, we purified MC-DPPI from mastocytoma cells.

42 duced degranulation of the BR line of canine mastocytoma cells.

43 o, but it has no such effect on lymphoma and mastocytoma cells.

44 privileged central nervous system using P511 mastocytoma cells.

45 s the regulation of gelatinase expression in mastocytoma cells.

46 not detectable in nonresponder lymphoma and mastocytoma cells.

47 denosine-mediated degranulation of canine BR mastocytoma cells; and (iii) the BR cell A2BAR couples t

48 ain a cDNA encoding the complete sequence of mastocytoma gelatinase B, a 2.3-kilobase clone encoding

49 o- and carboxyl-terminal halves of the above mastocytoma holoenzyme.

50 ned posttransplant relapse of the DBA/2 P815 mastocytoma in a murine model of MHC-matched, minor hist

51 tumor-specific CTL response against the P815 mastocytoma in the peritoneal cavity of preimmunized mic

52 NI-1 cells were found to form mastocytoma lesions in NOD/SCID IL-2Rgamma(null) mice an

53 ncoding progelatinase was isolated from a BR mastocytoma library.

54 strongly suggest that the above enzymes from mastocytoma, liver, and trachea, per se, are not solely

55 rowth in mice in a highly tumorigenic murine mastocytoma model.

56 om rat liver (NDST1) and another from murine mastocytoma (NDST2).

57 CM, and 10 patients presented with solitary mastocytoma of the skin.

58 In transplanted mastocytoma- or melanoma-bearing hosts, STAT5CA greatly

59 Cellular accumulation was enhanced in mastocytomas over primary mast cells, suggesting a mecha

60 + B lymphoblastoid cell lines and the murine mastocytoma p815 transfected with CD80 or CD86.

61 phoma (A20) cells, but not class II(-) mouse mastocytoma (P815) cells, supported IL-2 secretion of hy

62 15 minutes, in DBA/2 mice bearing either the mastocytoma, P815, which expresses the naturally occurri

63 NH2-terminal 13 amino acids of the purified mastocytoma progelatinase are 50-67% identical to those

64 liver NDANST that are conserved in the mouse mastocytoma protein produced three important findings re

65 d NIH 3T3 and some murine cancer cells (e.g. mastocytoma, sarcoma, and lymphoma), while lacking on ot

66 hows that cultured BR cells derived from dog mastocytomas secrete the 92-kDa proenzyme form of gelati

67 also following in vitro exposure of the P815 mastocytoma (that is negative for both B7-1 and B7-2 sur

68 timal primary tumor-specific CTL to the P815 mastocytoma, the EL4 thymoma, and the Lewis lung carcino

69 In mastocytomas, this pathway may facilitate tumor invasion

70 hibitor, dasatinib, on the c-KIT mutant P815 mastocytoma tumor were substantially dependent on T cell

71 y isolated from cells of a heparin-producing mastocytoma tumor.

72 t of mast cell neoplasms, we examined canine mastocytomas, which are among the most common tumors of